Available Technologies
# of Displayed Technologies: 3 / 3
Isolated Milk Phospholipids and MFGM
TS-045170 — Process for isolating and producing a high milk phospholipid ingredient from a by-product of the dairy industry, also commonly known as Milk Fat Globule Membrane (MFGM).
The Need: Revolutionizing Acid Whey Utilization for Increased Profitability and Sustainability
The dairy industry faces a critical challenge in effectively utilizing acid whey, a by-product generated during the production of cheese and Greek yogurt. Currently, acid whey is considered undesirable du…
- College: College of Food, Agricultural, and Environmental Sciences (CFAES)
- Inventors: Jimenez-Flores, Rafael; Ortega-Anaya, Joana
- Licensing Officer: Dahlman, Jason "Jay"
Ultra-Fast Charging Li-ion Battery Anodes
TS-040614 — A novel battery anode designed to overcome the limitations posed on fast charge batteries by graphite anodes. The new anode increases battery life, is more stable during manufacturing, and has improved heat dissipation qualities.
As technology continues to progress, embedding itself in our daily life from our cars to our wrists, an ever-present concern is the need for batteries with the ability to re-charge quickly. Most of these emerging technologies use Li-ion batteries with graphite anodes. Unfortunately, under fast cha…
- College: College of Arts & Sciences
- Inventors: Co, Anne; Bascaran, Julen
- Licensing Officer: Randhawa, Davinder
Compound 13, an Mps1/TTK Kinase Inhibitor, for Triple Negative Breast Cancer Therapy
TS-037724 — Researchers at The Ohio State University have discovered Compound 13, a patent protected, orally bioavailable and brain penetrant Mps1/TTK inhibitor that exhibits single agent tumor growth inhibition in a murine xenograft model of human triple negative breast cancer upon daily administration.
Breast cancer is a heterogeneous group of tumors, which can be subdivided based on histopathological features, genetic alterations, and gene-expression profiles. Approximately 50-60% of all breast cancer patients and two-thirds of postmenopausal breast cancer patients have estrogen receptor positi…
- College: College of Pharmacy
- Inventors: Brueggemeier, Robert; Fisk, Harold; Li, Chenglong; Li, Pui-Kai "Tom"; Sugimoto, Yasuro
- Licensing Officer: Schworer, Adam
